Teva Pharmaceutical has proposed to acquire drug maker Mylan NV for about $40 billion in cash and stock, a sign of the jockeying for dominance among generic drug makers.
WSJ.com: Europe Home, Wall Street Journal: World: Home Europe
Tue, 04/21/2015 - 6:19am
Teva Pharmaceutical has proposed to acquire drug maker Mylan NV for about $40 billion in cash and stock, a sign of the jockeying for dominance among generic drug makers.